共 118 条
[1]
Modlin IM(2003)A 5-decade analysis of 13,715 carcinoid tumors Cancer. 97 934-59
[2]
Lye KD(2012)Trends of incidence and survival of gastrointestinal neuroendocrine tumors in the United States: a seer analysis Journal of Cancer. 3 292-302
[3]
Kidd M(2008)One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States Journal of Clinical oncology: Official Journal of the American Society of Clinical Oncology. 26 3063-72
[4]
Tsikitis VL(2015)Gastric neuroendocrine tumors: prevalence in Europe, USA, and Japan, and rationale for treatment with a gastrin/CCK2 receptor antagonist Scandinavian Journal of Gastroenterology. 50 550-9
[5]
Wertheim BC(2009)Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-up Annals of Oncology : Official Journal of the European Society for Medical Oncology / ESMO. 20 150-3
[6]
Guerrero MA(2010)The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems Pancreas. 39 707-12
[7]
Yao JC(2016)A 15-year experience with gastric neuroendocrine tumors: does type make a difference? J Surg Oncol. 114 576-80
[8]
Hassan M(2014)Classification, clinicopathologic features and treatment of gastric neuroendocrine tumors World J Gastroenterol. 20 118-25
[9]
Phan A(1993)Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study Gastroenterology. 104 994-1006
[10]
Dagohoy C(2005)Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type Ann Surg. 242 64-73